Future Medicinal Chemistry

Future Medicinal Chemistry

未来药物化学

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Future Medicinal Chemistry》是由Future Science出版社于2009年创办的英文国际期刊(ISSN: 1756-8919,E-ISSN: 1756-8927),该期刊长期致力于药物化学领域的创新研究,主要研究方向为CHEMISTRY, MEDICINAL。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0786...%),以发表药物化学领域等方向的原创性研究为核心(研究类文章占比78.74%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在127篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Future Medicinal Chemistry审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单,年发文量约127篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 127 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CHEMISTRY, MEDICINAL 药物化学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
CHEMISTRY, MEDICINAL 药物化学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q3 39 / 72

46.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CHEMISTRY, MEDICINAL SCIE Q3 42 / 72

42.36%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.8 SJR:0.561 SNIP:0.599
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q2 128 / 313

59%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery Q2 72 / 157

54%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Molecular Medicine Q3 95 / 178

46%

期刊发文

  • Recent advances in anti-coxsackievirus A16 viral drug research

    Author: Yuan, Xiaolan; Liu, Ziwei; Wan, Li; Liu, Wei; Huang, Yan; Cao, Shuang

    Journal: FUTURE MEDICINAL CHEMISTRY. 2023; Vol. 15, Issue 1, pp. 97-117. DOI: 10.4155/fmc-2022-0195

  • Protective effects of a novel glycogen phosphorylase inhibitor against cerebral ischemia-reperfusion injury in mice

    Author: Yan, Zhiwei; Li, Shuai; Wang, Youde; Guo, Yachun; Zhang, Liying

    Journal: FUTURE MEDICINAL CHEMISTRY. 2023; Vol. 15, Issue 7, pp. 587-597. DOI: 10.4155/fmc-2023-0038

  • Recent advances in quinolone hybrids with potential antibacterial activity against drug-resistant bacteria

    Author: Jun, Wang; Shi, Yumin; Heng, Yan

    Journal: FUTURE MEDICINAL CHEMISTRY. 2023; Vol. 15, Issue 6, pp. 555-578. DOI: 10.4155/fmc-2023-0002

  • Design and synthesis of selective FLT3 inhibitors via exploration of back pocket II

    Author: Wang, Qing-Xin; Cao, Yu-Hao; Yang, Li-Jin; Ma, Yi-Yuan; Li, Nan; Wu, Shi-Han; Chen, Lu; Wu, Jia-Zhen; Tong, Zhen-Jiang; Wang, Xiao-Long; Xue, Xin; Ding, Ning; Leng, Xue-Jiao; Chang, Liang; Dai, Wei-Chen; Yu, Yan-Cheng; Sun, Shan-Liang; Yang, Ye; Li, Nian-Guang; Shi, Zhi-Hao

    Journal: FUTURE MEDICINAL CHEMISTRY. 2023; Vol. 15, Issue 1, pp. 57-71. DOI: 10.4155/fmc-2022-0231

  • Synergistic effect of bovine cateslytin-loaded nanoparticles combined with ultrasound against Candida albicans biofilm

    Author: Liu, Xian; Xu, Shan; Chen, Xiaoying; Kang, Shengnan; Liu, Jinglun; Jiang, Qihua; Zhang, Shu; Hao, Lan; Ran, Haitao; Huang, Wenxiang; Zhang, Dan

    Journal: FUTURE MEDICINAL CHEMISTRY. 2023; Vol. 15, Issue 1, pp. 43-55. DOI: 10.4155/fmc-2022-0062

  • An update on the recent advances and discovery of novel tubulin colchicine binding inhibitors

    Author: Weng, Haoxiang; Li, Jinlong; Zhu, Huajian; Wong, Kei Fung Carver; Zhu, Zheying; Xu, Jinyi

    Journal: FUTURE MEDICINAL CHEMISTRY. 2023; Vol. , Issue , pp. -. DOI: 10.4155/fmc-2022-0212

  • Novel anthraquinone derivatives trigger endoplasmic reticulum stress response and induce apoptosis

    Author: Zhai, Honglan; Wang, Chunmiao; Li, Junying; Liang, Dandan; Li, Fengming; Zhang, Qiuping; Wang, Jingni; Ma, Tuo; Li, Danrong; Hou, Huaxin

    Journal: FUTURE MEDICINAL CHEMISTRY. 2023; Vol. 15, Issue 1, pp. 129-145. DOI: 10.4155/fmc-2022-0217

  • Synthetic benzofuran-linked chalcones with dual actions: a potential therapeutic approach to manage diabetes mellitus

    Author: Ali, Irfan; Rafique, Rafaila; Khan, Khalid Mohammed; Chigurupati, Sridevi; Ji, Xingyue; Wadood, Abdul; Salar, Uzma; Almahmoud, Suliman A.; Rehman, Ashfaq Ur; Felemban, Shatha Ghazi; Hameed, Shehryar; Perveen, Shahnaz

    Journal: FUTURE MEDICINAL CHEMISTRY. 2023; Vol. 15, Issue 1, pp. 167-187. DOI: 10.4155/fmc-2022-0247